DexCom Incorporates Significant Revenue and Earnings Growth in Q2 2024

Monday, 29 July 2024, 14:04
DexCom, Inc. (NASDAQ: DXCM) has reported robust financial performance for Q2 2024, revealing a *15% increase* in total revenue year-over-year. The company's reported revenue reached *$1 billion*, with a *19% growth* in domestic markets and a *7% increase* internationally. Furthermore, DexCom has provided optimistic guidance for fiscal 2024, indicating continued growth in both revenue and adjusted earnings. This performance underlines DexCom's solid position in the healthcare sector.
AlphaStreet
DexCom Incorporates Significant Revenue and Earnings Growth in Q2 2024

DexCom Q2 2024 Financial Results

Healthcare company DexCom, Inc. (NASDAQ: DXCM) has announced its financial results for the second quarter of 2024, showcasing significant progress.

Key Financial Metrics

  • Revenue increased by 15% year-over-year.
  • Reported revenue reached $1 billion.
  • U.S. revenue experienced a growth of 19%.
  • International revenue grew 7%.

Future Guidance

DexCom is anticipated to maintain its positive trajectory, issuing guidance for continued growth in fiscal 2024.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe